Company profilePharmaceutical#334 of 1,318 in Pakistan✓ No DRAP alerts

PROGRESSIVE LABORATORIES

Pharmaceutical company · 53 brands · 53 molecules

Ranked #3 of 55 companies in Antidiarrheals, Intestinal Antiinflammatory/Antiinfective

53 registered products 25 pharmaceutical brands 53 distinct molecules 0 DRAP alerts

Company overview

53
registered products
25
pharmaceutical brands
53
distinct molecules
12
therapeutic classes
0
DRAP alerts

PROGRESSIVE LABORATORIES is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 53 product registrations across 53 distinct molecules. Its portfolio is concentrated in Antidiarrheals, Intestinal Antiinflammatory/Antiinfective and Vitamin B Complex Plain & With Vitamin C. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Paracetamol5 brands
Sodium Acid3 brands
Glycerin3 brands
Aspirin2 brands
Ors2 brands
Vitamin B Complex1 brand

Therapeutic classes

Antidiarrheals, Intestinal Antiinflammatory/Antiinfective · 4Vitamin B Complex Plain & With Vitamin C · 1Tetracyclines · 1Antihistamines For Systemic Use · 1Antianemic, Iron Preparations · 1Antimalarials · 1Antibiotics For Topical Use · 1Corticosteroids, Systemic Use · 1Other Analgesics And Antipyretics · 1Anthelmintic · 1Ectoparasiticides; Scabicides · 1Beta-Lactam Antibacterials, Penicillins · 1

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for PROGRESSIVE

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.